Two Sigma Securities’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-11,400
Closed -$408K 3128
2023
Q2
$408K Sell
11,400
-13,000
-53% -$373K 0.01% 1596
2023
Q1
$572K Buy
+24,400
New +$697K 0.01% 1168
2022
Q3
Sell
-13,900
Closed -$561K 2774
2022
Q2
$561K Buy
13,900
+10,200
+276% +$505K 0.02% 830
2022
Q1
$245K Buy
+3,700
New +$253K 0.01% 1573
2020
Q1
Sell
-7,100
Closed -$555K 1703
2019
Q4
$555K Buy
+7,100
New +$512K ﹤0.01% 1387

Other funds holding GH

Two Sigma Securities's GH Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Guardant Health (GH) in Q2 2026: 6,432 shares worth $965K. The stake represents 0.08% of the portfolio and ranks #305 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in GH as recently as Q3 2024.

Two Sigma Securities first reported a position in GH in Q1 2021 and has held it in 9 quarters since. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Two Sigma Securities held 6,432 shares of Guardant Health worth $965K as of Q2 2026.
  • Guardant Health was a new Two Sigma Securities position in Q2 2026.
  • Guardant Health made up 0.08% of Two Sigma Securities's portfolio in Q2 2026, its #305 holding.
  • Two Sigma Securities first reported a position in Guardant Health in Q1 2021 and has held it in 9 quarters since.
  • 600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.